Things you need to know:
– Sonde Health is expanding its leading health monitoring platform beyond mental and respiratory health with the introduction of an innovative cognitive fitness tracker that allows users to monitor brain activity, and therefore cognitive effort, in real time.
– The new solution, called Sonde Cognitive Fitness, analyzes eight voice characteristics from a 30-second voice interaction and generates a score to provide insights into a person’s cognitive state, helping people effectively manage their mental health and productivity.
Sonde Health: The leader in voice-based cognitive fitness monitoring
Sonde Health is at the forefront of voice-based health tracking and data analytics, delivering innovative solutions through its voice biomarker API/SDK. Serving a variety of enterprise applications from consumer health to population health, Sonde leverages comprehensive voice datasets and clinical research featuring over 1.2 million samples from 85,000+ individuals across four continents. Using advanced audio signal processing, speech science, and AI/machine learning, Sonde detects subtle voice changes that indicate changes in an individual’s physiology, providing critical insights into health and well-being.
Sonde Cognitive Fitness allows individuals to monitor their cognitive effort levels through a simple, passive 30-second audio sample collected on most smart devices. The tool measures audio biomarkers and generates a Cognitive Effort Score that is categorized as follows:
– Efficient (80-100): Low cognitive effort
– Balanced (70-79): Moderate cognitive effort
– Demanding (0-69): High cognitive effort
This feature allows users to optimize productivity, improve performance, and reduce cognitive strain.
The launch of Sonde Cognitive Fitness comes at a critical time when approximately one in five people over the age of 50 worldwide suffers from mild cognitive impairment (MCI) and more than 55 million people have dementia, a figure expected to almost triple by 2050. Highlighting the importance of early intervention, the US Food and Drug Administration (FDA) recently approved a second drug designed to delay the early stages of Alzheimer’s disease.
To develop Sonde Cognitive Fitness, Sonde Health collaborated with GN Group and clinical experts in cognitive disorders from renowned institutions such as Massachusetts General Hospital and Montefiore Medical Center at Albert Einstein College of Medicine. The research study involved approximately 700 older adults whose cognitive abilities were assessed with traditional tools such as the Addenbrooke Cognitive Assessment (ACE), Blessed Dementia Scale, and Clinical Dementia Rating (CDR) scale. Sonde’s Cognitive Fitness score showed high concordance with these traditional assessments.
Sonde ensures privacy and security through a rigorous verification process, collects voice samples only from users who register and consent, and does not store or transmit audio off-device. Sonde Cognitive Fitness is designed for seamless integration via APIs and SDKs, making it easy to deploy across platforms and devices.
By tracking cognitive performance, Sonde Health helps individuals maintain and enhance their cognitive abilities, providing an important tool in the global effort to combat cognitive decline and promote healthy aging.
